Market Overview
The global mice model market size
was valued at USD 1.4 billion in 2022 and is projected to reach USD 2.9 billion
by 2033, growing at a CAGR of 13.9 % during the forecast period.
Report Scope
Report Attributes |
Description |
Market Forecast in 2022 |
USD 1.4 billion |
Market Forecast in 2033 |
USD 2.7 billion |
CAGR % 2023-2033 |
13.9% |
Base Year |
2022 |
Historic Data |
2020-2021 |
Forecast Period |
2023-2033 |
Report USP |
Product, end-user industry, company share, company heat map, company
Capacity Technology Product capacity, growth factors and more |
Key Companies |
Applied StemCell, Inc.; Aragen
Life Sciences Ltd.; Biocytogen Boston Corporation; Charles River Laboratories
International, Inc.; CompareNetworks, Inc.; Creative Biolabs.; Crown
Bioscience by JSR Life Sciences, LLC; Cyagen US Inc. by PolyGene AG; Envigo
by Inotiv, Inc.; GenOway; Harbour BioMed; Others
|
Mice Model Market: Description
The global mice model market refers to the market for laboratory mice that are used as model organisms in scientific research and drug discovery. Mice models are widely used in various fields, including genetics, immunology, oncology, neurology, and toxicology, among others, to study human diseases and develop potential treatments.
Mice models are preferred in research due to their genetic similarity to humans, short reproductive cycle, small size, and ease of handling and maintenance in laboratory settings. They play a crucial role in understanding the underlying mechanisms of diseases, testing new drugs and therapies, and evaluating their efficacy and safety before human trials.
The mice model market encompasses the production, distribution, and usage of mice models in research institutions, pharmaceutical and biotechnology companies, contract research organizations, and academic laboratories worldwide. These mice models are typically genetically modified or selectively bred to mimic specific human diseases or conditions, such as cancer, diabetes, Alzheimer's disease, and cardiovascular disorders.
The market is driven by the increasing demand for personalized
medicine, growing prevalence of chronic diseases, advancements in genetic
engineering technologies, and rising investments in biomedical research.
Additionally, the need for more accurate and reliable animal models to reduce
the attrition rate in drug development further fuels the market growth.
Mice share a significant portion
of their genetic makeup with humans, making them excellent models for studying
human diseases and conditions. This similarity allows researchers to
investigate the molecular and genetic basis of various diseases and develop
effective therapies.
·
Rising
Demand For Personalized Medicine:
With the increasing focus on personalized medicine, there is a growing demand for mice models that closely mimic human genetics and diseases. Researchers are developing genetically modified mice models that carry specific mutations or genetic variations found in patient populations. These models enable the study of individualized treatment responses and facilitate the development of targeted therapies.
·
Expansion
of Humanized Mice Models:
Humanized mice models, where
human cells, tissues, or immune systems are engrafted into mice, are gaining
popularity. These models allow researchers to study human-specific diseases,
immune responses, and evaluate the efficacy of human-specific therapeutics. The
development of humanized mice models is driven by the need to bridge the gap
between preclinical research and clinical trials.
Mice Model Market: Segmental Analysis
By Technology
·
CRISPR/CAS9
·
Embryonic Stem Cell Injection
·
Nuclear Transfer
·
Other Technologies
By Mode
·
Outsourced
·
In-house
By Application
·
Oncology Studies
·
Cardiovascular Studies
·
Genetic Studies
·
Endocrine Metabolic Studies
·
Neurological Studies
·
Immunology & Inflammation studies
·
Other
Mice Model Market: Geographical Landscape
North America holds a prominent position in the mice model market. The United States, in particular, is a major contributor, driven by its robust biomedical research infrastructure, well-established regulatory framework, and presence of leading pharmaceutical and biotechnology companies.
Canada also has a notable presence in the market, with several research institutions and companies actively utilizing mice models for scientific research. Europe is another key region in the mice model market.
Countries such as the United Kingdom, Germany, France, and the Netherlands have
well-developed research infrastructure and a strong focus on biomedical
research. These countries host renowned academic institutions, contract
research organizations (CROs), and biopharmaceutical companies that extensively
use mice models for various research applications.
The Asia Pacific region has been experiencing significant growth in the mice model market. Countries like China, Japan, and South Korea have made substantial investments in biomedical research, resulting in the expansion of research capabilities and increased utilization of mice models.
Additionally, emerging economies such as India and Singapore are actively fostering research collaborations and attracting international research organizations and companies to establish their presence in the region.
Although the mice model market in the Middle East and Africa is relatively
smaller compared to other regions, there is a growing interest in biomedical
research and the use of mice models. Countries like Israel, Saudi Arabia, and
South Africa have research institutions and initiatives dedicated to advancing
scientific knowledge and promoting the use of animal models in research.
The pandemic caused disruptions in global supply chains, including the production and distribution of mice models. Restrictions on transportation, lockdown measures, and reduced workforce in breeding facilities and research institutions led to delays and shortages in the supply of mice models. This affected research activities that heavily rely on the availability of specific mouse strains. COVID-19 pandemic prompted a shift in research priorities towards studying the virus and developing treatments and vaccines.
Many research institutions and companies redirected
their resources and efforts towards COVID-19-related research, temporarily
reducing the demand for mice models in other areas of study. However, there has
also been an increased demand for mice models specifically for COVID-19
research and vaccine development.
The closure of research institutions, universities, and non-essential laboratories during the pandemic resulted in the temporary suspension or reduction of non-COVID-19 research activities.
This pause in research projects affected the demand for mice models, as studies were delayed or put on hold until the resumption of normal research operations. The urgent need for COVID-19 vaccines led to an unprecedented pace of vaccine development. Mice models, particularly genetically modified mice, played a crucial role in preclinical testing of vaccine candidates.
The mice model market witnessed an increased demand for
strains suitable for COVID-19 research, such as transgenic mice expressing
human ACE2 receptors.
The COVID-19 pandemic highlighted the importance of in vivo studies to understand disease mechanisms and evaluate potential therapeutics. Mice models, as a key tool for in vivo research, gained even more significance during the pandemic.
This emphasis on in vivo studies
may lead to a sustained demand for mice models beyond COVID-19 research, as
researchers recognize the value of studying diseases and developing treatments
in living organisms.
·
Applied StemCell, Inc.
·
Aragen Life Sciences Ltd.
·
Biocytogen Boston Corporation
·
Charles River Laboratories International, Inc.
·
CompareNetworks, Inc.
·
Creative Biolabs.
·
Crown Bioscience by JSR Life Sciences, LLC
·
Cyagen US Inc. by PolyGene AG
·
Envigo by Inotiv, Inc.
·
GenOway
· Harbour BioMed
Mice Model
Market: Regional Scope
North America
·
U.S
·
Canada
·
Mexico
Europe
·
U.K
·
Germany
·
France
·
Italy
·
Spain
·
Rest of Europe
Asia Pacific
·
Chain
·
India
·
Japan
·
South Korea
·
Australia
·
Rest of Asia pacific
South America
·
Brazil
·
Argentina
·
Rest of south America
Middle East and Africa
·
Saudi Arabia
·
UAE
·
Egypt
·
South Africa
· Rest of Middle East and Africa
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.
The global mice model market size was valued at USD 1.4 billion in 2022 and is projected to reach USD 2.9 billion by 2033, growing at a CAGR of 13.9 % during the forecast period.
With the increasing focus on personalized medicine, there is a growing demand for mice models that closely mimic human genetics and diseases.
Some of the major players operating within the market are Applied StemCell, Inc.; Aragen Life Sciences Ltd.; Biocytogen Boston Corporation; Charles River Laboratories International, Inc.; CompareNetworks, Inc.; Creative Biolabs.; Crown Bioscience by JSR Life Sciences, LLC; Cyagen US Inc. by PolyGene AG; Envigo by Inotiv, Inc.; GenOway; Harbour BioMed; Others
North America holds a prominent position in the mice model market. The United States, in particular, is a major contributor, driven by its robust biomedical research infrastructure, well-established regulatory framework, and presence of leading pharmaceutical and biotechnology companies.
Only Four Thousand Seven Hundred Fifty US dollar
Only Five Thousand Seven Hundred Fifty US dollar
Only Six Thousand Seven Hundred Fifty US dollar